Drug Database
Back to search

United States· US:0032-3016_94463229-9296-4640-854f-41d76386d312

Creon

A medicinal product containing pancrelipase amylase; pancrelipase lipase; pancrelipase protease, registered in United States by AbbVie Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCreonATC—REGISTER NO.US:0032-3016_94463229…PACKS LISTED6CHECKEDJuly 19, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pancrelipase amylase; pancrelipase lipase; pancrelipase proteaseAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
Manufacturer
AbbVie Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
July 19, 2026

Packs & prices · 6

  • ndc11
    0032-3016-12
  • ndc11
    0032-3016-13
  • ndc11
    0032-3016-28
  • ndc11
    0032301612
    1 BOTTLE in 1 CARTON (0032-3016-12) / 12 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE
  • ndc11
    0032301613
    100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-3016-13)
  • ndc11
    0032301628
    250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-3016-28)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebfe4427-829b-486c-b7eb-b27508dbfdd7
GET /v1/drugs/ebfe4427-829b-486c-b7eb-b27508dbfdd7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "180000; 36000; 114000",
  "substance": "PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE",
  "productndc": "0032-3016",
  "dosage_form": "CAPSULE, DELAYED RELEASE PELLETS",
  "dea_schedule": null,
  "strength_unit": "[USP'U]/1; [USP'U]/1; [USP'U]/1",
  "application_number": "BLA020725",
  "marketing_category": "BLA"
}
API referenceMCP serverPlans

See everything about pancrelipase amylase; pancrelipase lipase; pancrelipase protease.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console